BASFY — —
Loading…
— —
PREV CLOSE — OPEN — DAY RANGE —
Analyzing 0%
MASTER — —
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
SNAPSHOT
Ticker
BASFY
Company
BASF SE
Sector / Industry
Chemicals
Market Cap
€46.7B
Current Price
€14.72 −0.04 (−0.27%)
52W Range
€41.48 – €55.05
52W Return
+20.85%
Exchange
XETRA (DE)
EARNINGS MOMENTUM

EPS and Revenue Analysis (TTM & YoY Basis)

Metric Value Assessment
EPS (TTM) €6.65 Solid absolute earnings base
EPS Growth YoY +1,434.64% Exceptional recovery or base comparison effect; extraordinary growth rate
Revenue Growth YoY −4.91% Revenue headwinds; chemical sector cyclicality evident
Forward P/E 17.17x Below trailing P/E (28.89x); implies forward earnings expansion
Earnings Momentum Analysis:
Extraordinary YoY EPS growth (+1,434.64%) suggests a dramatic recovery from a depressed prior-year base or significant one-time benefit realization. However, this masks underlying revenue contraction (−4.91% YoY), indicating margin expansion rather than organic top-line strength. The chemical sector faces demand headwinds. Forward P/E compression (17.17x vs. 28.89x trailing) reflects market expectations of sustained profitability, though guidance and earnings dates remain undisclosed.
Earnings Momentum Score: 7.5/10 | Direction: Recovering with margin leverage; revenue weak
PROFITABILITY & QUALITY

Profitability Metrics & Quality Assessment

Metric Value Status
EPS €6.65 Strong absolute profitability per share
P/E Ratio (Trailing) 28.89x Premium valuation for chemicals sector
Dividend Yield 7.63% Attractive income; €2.35/share annual dividend
PEG Ratio 0.020 Exceptional growth-adjusted valuation
Gross/Op/Net Margin Data constrained Limited visibility; inferred strong net margins from EPS/market cap
ROE / ROIC Data constrained Not disclosed; assess via dividend yield and EPS quality
Quality Assessment:
BASF demonstrates strong absolute profitability (€6.65 EPS) backed by a 7.63% dividend yield, signaling confident capital returns. The PEG ratio of 0.020 is exceptionally low, indicating earnings growth substantially outpaces valuation. However, the absence of detailed margin and return-on-capital data limits full quality assessment. The revenue decline YoY suggests operational headwinds in underlying business fundamentals, offset by cost discipline.
Quality Score: 5.5/10 | Verdict: Dividend-supported profitability with margin resilience; structural revenue challenges
BALANCE SHEET HEALTH

Financial Position & Leverage Assessment

Metric Value / Status Implication
Cash & Liquidity Data constrained Not disclosed in available financials; material gap for large-cap assessment
Total Debt / Net Debt Data constrained Limited visibility; €46.7B market cap suggests substantial debt base typical for diversified chemical conglomerate
Net Debt/EBITDA Data constrained Not disclosed; material metric for cyclical sector
Interest Coverage Data constrained Unable to assess; critical gap for debt servicing capacity
Current Ratio Data constrained Not disclosed; operational liquidity assessment limited
Beta 0.301 Low systematic risk; defensive profile
Shareholder Dilution Data constrained No recent dilution flags evident; stable share structure assumed
Balance Sheet Health Assessment:
Coverage is materially constrained by missing balance sheet and cashflow statements. BASF's low beta (0.301) indicates resilient, defensive market positioning. As a large-cap industrial conglomerate, typical leverage metrics warrant scrutiny in a cyclical downturn environment (evidenced by −4.91% revenue YoY). The 7.63% dividend yield maintained during revenue contraction signals confidence in cash generation, but detailed debt structure and liquidity buffers remain opaque.
Balance Sheet Risk: MEDIUM | Status: Defensive profile offset by data gaps; cyclical sector exposure
VALUATION ANALYSIS

Valuation Multiples & Relative Assessment

Metric Value Assessment vs. Sector
Trailing P/E 28.89x Premium to chemicals sector median (~15–18x); elevated
Forward P/E 17.17x In-line with sector; near-term earnings expansion priced in
PEG Ratio 0.020 Deeply attractive; exceptional growth-adjusted value
Price / Sales Data constrained Revenue TTM not disclosed; unable to calculate
EV / EBITDA Data constrained Not disclosed; enterprise value available but EBITDA missing
Dividend Yield 7.63% Attractive absolute yield; provides valuation floor & income support
Valuation Synthesis:
BASF trades at a premium trailing P/E (28.89x) reflective of earnings recovery premium, but forward P/E (17.17x) suggests mean reversion toward sector norms. The extraordinary PEG ratio (0.020) indicates the market underprices growth relative to valuation—a potential value opportunity if +1,434% EPS growth proves sustainable. The 7.63% dividend yield acts as a valuation anchor and return floor. However, structural revenue weakness (−4.91% YoY) and sector cyclicality warrant cautious interpretation of multiple expansion sustainability.
Valuation Status: FAIRLY VALUED TO ATTRACTIVE | Forward P/E reasonable; PEG deeply compelling but dependent on earnings sustainability
ANALYST TARGETS & SENTIMENT

Wall Street Research & Price Targets

Metric Value Implication
Consensus Rating Data constrained Not disclosed; analyst coverage not available in dataset
Price Target (Mean) Data constrained Not disclosed; target_price_mean returns null
Price Target (High) Data constrained Not disclosed; no consensus high estimate
Price Target (Low) Data constrained Not disclosed; no consensus low estimate
Implied Upside / Downside Data constrained Unable to calculate without consensus targets
Target Dispersion Data constrained Not disclosed; analyst consensus breadth unknown
Analyst Sentiment Assessment:
Detailed analyst research coverage is unavailable in the current dataset. Price targets, consensus ratings, and research dispersion metrics are not disclosed, preventing quantitative sentiment assessment. This represents a material gap for institutional decision-making. Based on public market behavior (52W return of +20.85% and current forward P/E of 17.17x), the market appears cautiously constructive, pricing in earnings normalization rather than consensus upside surprise.
Wall Street Sentiment: CONSTRAINED VISIBILITY | Coverage data unavailable; market pricing suggests measured optimism with earnings recovery priced in
INSTITUTIONAL & RISK CHECK

Ownership, Insider Activity & Risk Flags

Factor Status / Value Risk Assessment
Institutional Ownership Trend Data constrained Not disclosed; large-cap XETRA listing typically held widely by EU institutions
Insider Buying / Selling Data constrained Not disclosed; material signal unavailable
Short Interest Data constrained Not disclosed; cannot assess bearish sentiment or short squeeze risk
High Valuation Flag FALSE System assessment: valuation not extreme despite P/E premium
Hyper-Growth Flag FALSE Despite +1,434% EPS growth, revenue decline prevents hyper-growth classification
Strong Profitability Flag FALSE Adequate earnings (6.65 EPS) but modest relative to market cap; margin data unavailable
Weak Balance Sheet Flag FALSE Low beta (0.301) and sustained dividend suggest stable financial position
Cyclical Sector Risk ELEVATED Chemicals sector in contraction (−4.91% revenue YoY); macro sensitivity high
Earnings Sustainability Risk MODERATE-HIGH +1,434% EPS growth likely unsustainable; base comparison effect or one-time gains probable
Risk Summary:
BASF carries moderate-to-elevated risk profile driven by cyclical chemical sector exposure (evidenced by −4.91% revenue contraction), extraordinary but likely non-sustainable earnings growth (+1,434% YoY), and material data gaps in balance sheet detail. Institutional ownership and insider flow data are unavailable, limiting sentiment triangulation. The system's absence of red flags on valuation, growth, profitability, and balance sheet suggests baseline financial stability, but structural headwinds in the sector warrant caution. Low beta (0.301) provides downside mitigation.
Risk Level: MODERATE | Primary Risks: Cyclical sector weakness, earnings growth sustainability, macro sensitivity
60
Overall Fundamental Score (0–100)
ESEN Composite Assessment
Conviction Level: MODERATE
Supported by strong dividend yield (7.63%), attractive forward P/E (17.17x), and exceptional PEG ratio (0.020). Tempered by structural revenue weakness (−4.91% YoY), extraordinary but potentially unsustainable EPS growth (+1,434%), and material data gaps in financial detail (balance sheet, cashflow, earnings guidance).
TIME HORIZON OUTLOOK
SHORT (1–3M)
HOLD
Cyclical headwinds persist; watch guidance
MEDIUM (6–12M)
BUY
Dividend income + earnings recovery
LONG (2Y+)
BUY
Structural recovery + dividend growth
FINAL VERDICT (5 KEY POINTS)
  • Earnings Recovery Play: +1,434% YoY EPS growth, though likely cyclical/base-driven; forward P/E (17.17x) implies earnings normalization expectations embedded.
  • Dividend Fortress: 7.63% yield with €2.35/share payout maintained despite −4.91% revenue contraction; signals strong dividend policy and cash generation confidence.
  • Valuation Opportunity: PEG ratio of 0.020 is exceptionally compelling; forward P/E near sector median (17.17x) suggests downside-protected entry for 6–12M horizon.
  • Sector Cyclicality Risk: Chemical industry headwinds evident in revenue decline; macro sensitivity elevated; low beta (0.301) provides defensive hedge but does not offset industry structural challenges.
  • Data Gaps Require Monitoring: Balance sheet detail, cashflow trends, earnings guidance, and analyst targets unavailable; recommend accessing full financial statements and Q-earnings releases before material position increases.
ESEN Fundamental + Earnings Master | Analysis as-of 2026-10-26 | Data Source: Finnhub

BASFY Stock AI Analysis

ESEN AI analysis of BASFY stock updated every 12 hours.

AI STOCK INSIGHT

BASFY Stock Analysis & Forecast

Is BASFY a Good Investment in 2026?

Our model indicates a neutral outlook based on current fundamentals and momentum.

BASFY Stock Forecast

Based on recent earnings trends, valuation metrics, and sector performance, BASFY shows balanced risk-reward characteristics.

Should You Buy BASFY Now?

Investors should consider market conditions, volatility, and long-term positioning before taking a position in BASFY.

Related Stocks
AAPL NVDA MSFT AMZN GOOGL META TSLA AVGO JPM V MA LLY UNH XOM JNJ WMT PG HD MRK COST BAC ABBV CRM CVX ORCL KO PEP AMD NFLX ADBE

Explore AI analysis for top stocks — Full Rankings · AI Screener · Earnings Calendar